FDA Will Regulate Diagnostic Tests. Yes, Those for Alzheimer’s, Too.

News
Written By Emily Scholler
Emily Scholler
Previous

The Global CEO Initiative on Alzheimer’s Disease Comment on the World Health Organization’s Preferred Product Characteristics for Blood Tests for Alzheimer’s Disease
Next

The Global CEO Initiative on Alzheimer’s Disease Announces Expansion of its Blood-Based Biomarker Workgroup in 2024